Exact Sciences (EXAS) 10-Q2024 Q1 Quarterly report

Filed: 8 May 24, 5:03pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: AACR, adjuvant, aggressive, automation, broader, chance, channel, characterized, clarity, conflict, Cosmetic, coverage, decade, earnout, endorsed, explicit, framework, furniture, Gallup, geopolitical, guide, high, HR, infrastructure, insignificant, introducing, Japanese, lapse, magnify, main, minimal, module, MolDx, multinational, neoadjuvant, Oxford, permitted, phase, Pillar, PlusTM, preliminarily, premarket, prohibited, proven, PSU, published, rare, reinvest, removal, remove, removed, rescreening, retrospectively, Riskguard, semiannually, Simplification, spared, stayed, submitted, transparency, underserved, unnecessary, upcoming, variety, withheld, women, Workplace

Removed: accelerate, accelerated, accelerating, achieving, adequately, administer, advertising, affiliate, alleged, alleging, amid, assay, behalf, Biomatrica, biopsy, borrow, calculated, calendar, charge, collect, complaint, constrained, Court, cover, decline, decreasing, deliver, design, digital, discover, discovery, disposed, District, divested, Dr, efficiency, efficiently, employing, enrollment, expertise, fee, fewer, flexibly, Florida, force, fourth, fully, Germany, gift, grow, growing, guideline, half, Hope, incremental, Indenture, insurance, intervention, invasive, investigation, labor, leadership, learned, live, local, Madison, matter, MCED, media, Middle, modification, notice, occurred, overlap, owed, pandemic, parte, partially, partnered, path, Pfizer, Planegg, prevent, prioritization, produced, promising, promote, promoting, promotion, protein, proteome, provision, pursuing, qualifying, ratably, reimburse, relationship, released, reliable, repaid, responsible, restructured, restructuring, retroactively, returning, Rosen, saving, sealed, shared, specifically, Statute, technological, trained, translated, treble, turnover, underway, valuable, violation, world

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated EXAS transcripts

EXAS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Exact Sciences Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Kevin T. Conroy, President and Chief Executive Officer of the Company and Jeffrey T. Elliott, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to our knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: May 8, 2024	/s/ Kevin T. Conroy
	Name:	Kevin T. Conroy
	Title:	President and Chief Executive Officer
		(Principal Executive Officer)

Dated: May 8, 2024	/s/ Jeffrey T. Elliott
	Name:	Jeffrey T. Elliott
	Title:	Executive Vice President and Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)